[Erythrocyte substitution and isoagglutinin titer following ABO-incompatible bone marrow transplantation].
About 2 or 3 weeks after transplantation, even ABO-Incompatible bone marrow shows a successful graft. Haemopoiesis is not always free of problems. Suppression of erythropoiesis is caused by persistently incompatible agglutinins. Patient's well-being is limited by longer periods of low levels of haemoglobin concentration. Long-lasting need for transfusions is related to the well-known risk of infections. A procedure to eliminate the residual titers of alloantibodies should be discussed in time with the staff of the transfusion department.
Henneberg-Quester
K B
KB
Blutspende- und Transfusionsdienst, Universitätsklinikum Essen.
Luboldt
W
W
Schaefer
U W
UW
Beelen
D W
DW
Quabeck
K
K
D000017:ABO Blood-Group System / Q000276:immunology*; D001787:Blood Group Incompatibility / Q000097:blood / Q000517:prevention & control*; D001788:Blood Grouping and Crossmatching / Q000379:methods*; D001803:Blood Transfusion / Q000379:methods*; D016026:Bone Marrow Transplantation / Q000379:methods*; D017707:Erythrocyte Transfusion; D006650:Histocompatibility Testing / Q000379:methods*; D006801:Humans; D007518:Isoantibodies / Q000378:metabolism*; D010951:Plasma Exchange / Q000379:methods
D000017:ABO Blood-Group System; D007518:Isoantibodies
Erythrozytensubstitution und Isoagglutinintiter nach ABO-inkompatibler Knochenmark-transplantation.